Shengjie Wang
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 13
- MicroRNA in disease regulation 5
- Molecular Biology top 10%
- RNA modifications and cancer 8
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 5
- RNA Research and Splicing 5
-
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 2
- Co-authors
- Zhe LeiHongtao ZhangZhiyue SuZeyi LiuCuijuan ZhangXin TongJun ZhaoYuanyuan Zeng
In The Last Decade
Shengjie Wang
38 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 98
- Cancer Research 592
- Molecular Biology 812
- Oncology 135
- Pathology and Forensic Medicine 49
- Immunology 54
Countries citing papers authored by Shengjie Wang
This map shows the geographic impact of Shengjie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjie Wang more than expected).
Fields of papers citing papers by Shengjie Wang
This network shows the impact of papers produced by Shengjie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjie Wang. The network helps show where Shengjie Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengjie Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 9 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 15 | |
| 13 | 2022 | 19 | |
| 14 | 2022 | 35 | |
| 15 | 2021 | 37 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 39 | |
| 18 | 2018 | 277 | |
| 19 | 2018 | 148 | |
| 20 | 2018 | 9 |
About Shengjie Wang
Shengjie Wang is a scholar working on Cancer Research, Health Informatics and Molecular Biology, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (8 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers), Epigenetics and DNA Methylation (5 papers), RNA Research and Splicing (5 papers), Cancer Cells and Metastasis (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Cancer Research (592 citations), Molecular Biology (812 citations) and Oncology (135 citations). Shengjie Wang has collaborated with scholars based in China, India and Japan. Frequent co-authors include Zhe Lei, Hongtao Zhang, Zhiyue Su, Zeyi Liu, Cuijuan Zhang, Xin Tong, Jun Zhao, Yuanyuan Zeng, Xia Liu and Zhengyu Zhou. Their work appears in journals such as Oncogene, Scientific Reports and Developmental Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.